PMID: 11930187Apr 4, 2002Paper

Clinical assessment in ischaemic cardiomyopathy

Nuclear Medicine Communications
E Putz, R Vagelos

Abstract

Despite the trend of decreasing death rates attributable to ischaemic heart disease and stroke, the prevalence of heart failure and the resultant death rates in the United States have almost tripled between 1974 and 1994 [1]. Coronary artery disease is the commonest cause of heart failure in developed countries, accounting for up to 60% of cases. Advances in medical therapy, particularly the use of angiotensin-converting enzyme inhibitors and beta-blockers, have served to reduce morbidity and mortality in patients with left ventricular (LV) dysfunction due to coronary artery disease [2-5]. However, these improvements have been modest, and despite these therapies, patients with severe ischaemic cardiomyopathy continue to have a high mortality when treated medically. It is increasingly clear that the impaired LV function in these patients is not always an irreversible process. Traditionally, these observations have been made following demonstrable improvements in systolic function after coronary revascularization procedures. Diagnostic testing to evaluate the presence and extent of viable myocardium has therefore become an important component of the clinical assessment of patients with chronic coronary artery disease and LV dysfu...Continue Reading

References

Aug 1, 1975·The American Journal of Cardiology·H J ZeftW D Johnson
Aug 1, 1991·The New England Journal of Medicine·UNKNOWN SOLVD InvestigatorsJay N Cohn
Aug 11, 1988·The New England Journal of Medicine·E Varnauskas
Nov 22, 1984·The New England Journal of Medicine·UNKNOWN Veterans Administration Coronary Artery Bypass Surgery Cooperative Study Group
Dec 1, 1982·Circulation·E Braunwald, R A Kloner
Sep 1, 1993·The Annals of Thoracic Surgery·C A MilanoP Van Trigt
Mar 1, 1993·The Annals of Thoracic Surgery·G B LucianiA Mazzucco
Dec 1, 1996·Circulation·R O Bonow
Jun 1, 1997·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·M G GunningS R Underwood
May 15, 1998·Journal of the American College of Cardiology·N ZafrirS T Dahlberg
Aug 10, 2000·European Journal of Heart Failure·D PaganoR S Bonser

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.